Recent research has illustrated this adaptability; for instance, mRNA vaccines have been rapidly repurposed for addressing viral infections, showcasing a paradigm that can be applied to CVDs for delivering therapeutic factors, such as endothelial nitric oxide synthase (eNOS) mRNA to enhance endothelial function (52). The gene discussed is NOS3; the disease is viral infectious disease.